Literature DB >> 3686352

Parathyroid metabolism after operative treatment of hypercalcemic (primary) hyperparathyroidism.

G L Irvin1, D J Newell, S D Morgan.   

Abstract

Parathyroidectomy is usually followed by a decrease in serum calcium, a lessening of symptoms, and a normocalcemic state that continues for years. Evaluation of parathyroid gland function after parathyroidectomy over a protracted period showed a continued hypersecretory state in many normocalcemic patients and is reported here for the first time. Patients identified with parathyroid hyperplasia (more than one gland excised) and patients who later developed mild renal failure were excluded. Seventy-seven patients undergoing parathyroidectomy with only one enlarged gland removed and the other normal-sized glands viewed or examined by biopsy were followed up from 5 to 16 years. Two patients developed recurrent hypercalcemia at 4 and 9 years after surgery. Seventy-five patients are considered "cured" and have normal serum calcium values. However, 28 (37%) of these normocalcemic patients have persistent elevations of parathyroid hormone. This increased parathyroid gland function suggests a continuing stimulation of the remaining glands. The rarity of clinical recurrence may be related to effective adaptations that prevent overt hypercalcemia. Many parathyroid adenomas appear to represent nonneoplastic disease.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3686352

Source DB:  PubMed          Journal:  Surgery        ISSN: 0039-6060            Impact factor:   3.982


  12 in total

1.  Normocalcemia with persistent increase of parathyroid hormone: a prospective study.

Authors:  H Mulder; W H Hackeng; J Koster; H van der Schaar
Journal:  Calcif Tissue Int       Date:  1992-07       Impact factor: 4.333

2.  Hypercalcemia due to hyperparathyroidism treated with a somatostatin analogue.

Authors:  D Miller; M W Edmonds
Journal:  CMAJ       Date:  1991-08-01       Impact factor: 8.262

3.  Preoperative serum osteocalcin may predict postoperative elevated parathyroid hormone in patients with primary hyperparathyroidism.

Authors:  Nahid Rianon; Gillian Alex; Glenda Callender; Camilo Jimenez; Mimi Hu; Elizabeth Grubbs; Mauricio Moreno; Chetna Wathoo; Steven Petak; Nancy Perrier
Journal:  World J Surg       Date:  2012-06       Impact factor: 3.352

4.  Normalization of 2-week postoperative parathyroid hormone values in patients with primary hyperparathyroidism: four-gland exploration compared to focused-approach surgery.

Authors:  Peter J Mazzaglia; Mira Milas; Eren Berber; Alan Siperstein; Jack M Monchik
Journal:  World J Surg       Date:  2010-06       Impact factor: 3.352

Review 5.  Elevated parathyroid hormone levels after successful parathyroidectomy for primary hyperparathyroidism: a clinical review.

Authors:  Roberto de la Plaza Llamas; José Manuel Ramia Ángel; Vladimir Arteaga Peralta; Cristina García Amador; Aylhín Joana López Marcano; Aníbal Armando Medina Velasco; Begoña González Sierra; Alba Manuel Vázquez; Raquel Aránzazu Latorre Fragua
Journal:  Eur Arch Otorhinolaryngol       Date:  2017-12-05       Impact factor: 2.503

6.  A new approach to parathyroidectomy.

Authors:  G L Irvin; D L Prudhomme; G T Deriso; G Sfakianakis; S K Chandarlapaty
Journal:  Ann Surg       Date:  1994-05       Impact factor: 12.969

7.  Study of intact (1-84) parathyroid hormone secretion in patients undergoing parathyroidectomy.

Authors:  C Davies; M J Demeure; A St John; A J Edis
Journal:  World J Surg       Date:  1990 May-Jun       Impact factor: 3.352

8.  Intraoperative and postoperative PTH secretion mode in patients with hyperparathyroidism.

Authors:  S Fischer; D Flentje; C Kettelhack; J Schmidt-Gayk; H Buhr; C Herfarth
Journal:  World J Surg       Date:  1990 May-Jun       Impact factor: 3.352

9.  The cause of maintained hypercalciuria after the surgical cure of primary hyperparathyroidism is a defect in renal calcium reabsorption.

Authors:  M L Farias; A G Delgado; D Rosenthal; J G Vieira; T Kasamatsu; M J Lazarevitch; M F Pereira; M B Lima
Journal:  J Endocrinol Invest       Date:  1996-01       Impact factor: 4.256

10.  Normocalcemia and persistent elevated serum concentrations of 1-84 parathyroid hormone after operation for sporadic parathyroid adenoma: evidence of increased morbidity from cardiovascular disease.

Authors:  Henrik Vestergaard; Lars ØStergaard Kristensen
Journal:  World J Surg       Date:  2002-03-01       Impact factor: 3.352

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.